Cardiome shuffles appointments
This article was originally published in Scrip
Executive Summary
The Canadian drug development company Cardiome Pharma, which focuses on novel treatments for heart and circulatory system disorders, has appointed Doug Jazen president and CEO and Bob Reider executive chairman.